Latest Innovation Funding News

Airtasker has landed a £2.5 million media investment from Channel 4’s venture arm to accelerate growth in the UK, building on a strong marketplace performance and deepening a strategic media partnership.

Torque Metals secures $2.8 million from early option exercises, boosting funding for its Paris Gold Project exploration in Western Australia.

Everest Metals has received $150,000 from the Minerals Research Institute of Western Australia to advance rubidium extraction at its Mt Edon project, aiming to establish Australia’s first commercial rubidium industry and reduce reliance on Chinese supply chains.

Centrepoint Alliance has reported a robust FY25 with 13% revenue growth and a 30% increase in profit before tax, driven by organic adviser expansion, strategic acquisitions, and pioneering technology investments including AI and cybersecurity.

Tuas Limited, through its subsidiary Simba Telecom, has announced a transformative acquisition of M1 Limited’s non-ICT businesses for S$1.43 billion, accompanied by a substantial equity raising and debt financing plan.

Hartshead Resources NL reports steady progress on its P2607 gas development in the UK Southern North Sea, supported by a strong cash position and ongoing joint venture negotiations with RockRose Energy.

Strategic Elements Ltd has marked significant progress in its Energy Ink™ prototype trials and underground mining technology, maintaining a robust financial footing with $4.21 million cash and no debt.

Centrepoint Alliance has reported a robust FY25 with EBITDA rising 16% and net profit before tax jumping 30%, driven by strong adviser growth and strategic platform launches.

Butn Limited announces the planned retirement of Co-CEO Walter Rapoport, transitioning him to a Non-Executive Director role by September 2025, marking a significant leadership shift for the fintech.

Acrux Limited has secured a further $0.46 million advance on its FY25 R&D Tax Incentive, bringing total advances to $2.19 million and supporting its pharmaceutical product development and working capital needs.

Rhythm Biosciences has obtained a $1 million non-dilutive loan backed by its FY2025 R&D Tax Incentive rebate, aiming to accelerate the commercial rollout of its ColoSTAT® test and expand its geneType™ platform.

Assetora Australia Limited has been officially appointed as the Responsible Entity of the DomaCom Fund, lifting previous restrictions and paving the way for renewed investment activity and secondary market trading.